PF-05212384
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for PF-05212384, covering 2014-09-04 to 2021-10-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC) [Phase 1]